Takeharu Yamanaka

21.0k total citations · 5 hit papers
344 papers, 10.6k citations indexed

About

Takeharu Yamanaka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Takeharu Yamanaka has authored 344 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Oncology, 161 papers in Pulmonary and Respiratory Medicine and 60 papers in Surgery. Recurrent topics in Takeharu Yamanaka's work include Colorectal Cancer Treatments and Studies (100 papers), Lung Cancer Treatments and Mutations (95 papers) and Gastric Cancer Management and Outcomes (60 papers). Takeharu Yamanaka is often cited by papers focused on Colorectal Cancer Treatments and Studies (100 papers), Lung Cancer Treatments and Mutations (95 papers) and Gastric Cancer Management and Outcomes (60 papers). Takeharu Yamanaka collaborates with scholars based in Japan, United States and United Kingdom. Takeharu Yamanaka's co-authors include Yoshihiko Maehara, Nobuyuki Yamamoto, Takashi Seto, Kōichi Goto, KAZUO OKUNUKI, Ryota Ishiwata, Yoji Nagai, Shigemi Matsumoto, Satoshi Teramukai and Noboru Yamamoto and has published in prestigious journals such as Physical Review Letters, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Takeharu Yamanaka

328 papers receiving 10.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

2010 1.3k citations Anne Aupérin, C. Le Péchoux et al. Journal of Clinical Oncology profile →
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

2015 598 citations Kento Imajo, Takaomi Kessoku et al. profile →
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

2014 561 citations Takashi Seto, Shinji Atagi et al. profile →
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

2017 308 citations Takeharu Yamanaka, Takashi Seto et al. profile →
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer

2018 225 citations Takashi Seto, Takeharu Yamanaka et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takeharu Yamanaka Japan	51	4.8k	4.5k	2.0k	1.6k	1.5k	344	10.6k
Donna Hollis United States	55	5.9k 1.2×	4.6k 1.0×	3.0k 1.5×	656 0.4×	1.3k 0.8×	154	11.4k
Marek Ancukiewicz United States	47	3.3k 0.7×	4.3k 1.0×	2.1k 1.0×	1.7k 1.1×	2.4k 1.6×	127	11.8k
Xavier Filella Spain	56	2.7k 0.6×	2.7k 0.6×	1.2k 0.6×	2.1k 1.3×	2.4k 1.6×	242	9.2k
Lorenzo Spaggiari Italy	49	2.9k 0.6×	6.3k 1.4×	2.0k 1.0×	1.0k 0.7×	1.6k 1.1×	507	10.4k
Sarah Burdett United Kingdom	26	3.6k 0.8×	5.3k 1.2×	1.9k 1.0×	686 0.4×	1.3k 0.9×	56	9.8k
Christoph A. Binkert Switzerland	43	1.9k 0.4×	2.6k 0.6×	3.3k 1.7×	1.2k 0.8×	1.1k 0.8×	164	9.1k
Marianne Paesmans Belgium	57	7.9k 1.7×	4.3k 1.0×	1.0k 0.5×	1.7k 1.1×	2.3k 1.5×	337	13.0k
John J. Crowley United States	59	8.0k 1.7×	8.8k 2.0×	2.0k 1.0×	1.5k 0.9×	3.9k 2.5×	195	17.8k
Dino Amadori Italy	60	6.7k 1.4×	3.1k 0.7×	1.6k 0.8×	823 0.5×	4.5k 3.0×	351	14.2k
Hendrik Dienemann Germany	52	2.8k 0.6×	4.7k 1.1×	1.5k 0.7×	553 0.4×	2.3k 1.5×	236	8.8k

Countries citing papers authored by Takeharu Yamanaka

Since Specialization

Citations

This map shows the geographic impact of Takeharu Yamanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeharu Yamanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeharu Yamanaka more than expected).

Fields of papers citing papers by Takeharu Yamanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeharu Yamanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeharu Yamanaka. The network helps show where Takeharu Yamanaka may publish in the future.

Co-authorship network of co-authors of Takeharu Yamanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Takeharu Yamanaka. A scholar is included among the top collaborators of Takeharu Yamanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeharu Yamanaka. Takeharu Yamanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mihara, Takahiro, et al.. (2021). Effect of melatonin and melatonin agonists on postoperative sleep quality in adult patients: a protocol for systematic review and meta-analysis with trial sequential analysis. BMJ Open. 11(9). e047858–e047858. 5 indexed citations

Yoneda, Masato, Yasushi Honda, Yuji Ogawa, et al.. (2021). Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial. BMJ Open Diabetes Research & Care. 9(1). e001990–e001990. 78 indexed citations

Kagawa, Yoshinori, Élena Elez, Jesús García‐Foncillas, et al.. (2021). Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study. Clinical Cancer Research. 27(9). 2515–2522. 45 indexed citations

Nakajima, Takako Eguchi, Shigenori Kadowaki, Keiko Minashi, et al.. (2020). Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer. Clinical Cancer Research. 27(4). 1029–1036. 63 indexed citations

Kotaka, Masahito, Shigeyoshi Iwamoto, Hironaga Satake, et al.. (2020). Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study). International Journal of Clinical Oncology. 25(8). 1515–1522. 4 indexed citations

Okuyama, Hiroyuki, Masafumi Ikeda, Takuji Okusaka, et al.. (2020). A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial). Neuroendocrinology. 110(11-12). 988–993. 17 indexed citations

Taniguchi, Hiroya, Takeharu Yamanaka, Daisuke Sakai, et al.. (2020). Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G. Cancers. 12(7). 1715–1715. 8 indexed citations

Akamatsu, Hiroaki, Shunsuke Teraoka, Yasuhiro Koh, et al.. (2018). A Phase II Study of Nivolumab in Patients With Advanced Non–small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L). Clinical Lung Cancer. 20(2). 139–141. 5 indexed citations

Sawada, Kentaro, Yoshiaki Nakamura, Takeharu Yamanaka, et al.. (2018). Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 17(3). 198–205. 62 indexed citations

10.

Oki, Eiji, Takeshi Kato, Hideaki Bando, et al.. (2018). A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study. Clinical Colorectal Cancer. 17(2). 147–155. 32 indexed citations

11.

Kogure, Yoshihito, Hideo Saka, Yuichi Takiguchi, et al.. (2018). A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol. Clinical Lung Cancer. 19(5). e711–e715. 8 indexed citations

12.

Shimokawa, Tsuneo, et al.. (2018). Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations. BMC Cancer. 18(1). 1012–1012. 8 indexed citations

13.

Yoshino, Takayuki, Takeharu Yamanaka, Masahito Kotaka, et al.. (2017). Efficacy of 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer (CC): Results from phase III ACHIEVE trial as part of the International Duration Evaluation of Adjuvant therapy (IDEA) Collaboration. Annals of Oncology. 28. v614–v614. 6 indexed citations

14.

Ota, Keiichi, Yoshimasa Shiraishi, Taishi Harada, et al.. (2017). OA08.02 Phase II Study of Erlotinib in Advanced Non-Small Cell Lung Cancer Patients with Leptomeningeal Metastasis (LOGIK1101). Journal of Thoracic Oncology. 12(1). S271–S272. 10 indexed citations

15.

Endo, Hiroki, Takayuki Kato, Eiji Sakai, et al.. (2016). Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?. Journal of Gastroenterology. 52(2). 194–202. 7 indexed citations

16.

Renfro, Lindsay A., Axel Grothey, James Paul, et al.. (2014). Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting Analysis Dates for the IDEA Collaboration. SHILAP Revista de lepidopterología. 5(2). 1–7. 1 indexed citations

17.

Aupérin, Anne, C. Le Péchoux, Estelle Rolland, et al.. (2010). Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 28(13). 2181–2190. 1329 indexed citations breakdown →

18.

Tokunaga, Eriko, Eiji Oki, Yasue Kimura, et al.. (2006). Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma. Breast Cancer Research and Treatment. 101(3). 249–257. 38 indexed citations

19.

Yamazaki, T., F. Naito, S. Ohtake, et al.. (1984). A NEW IMPROVED EXPERIMENT TO SEARCH FOR HEAVY NEUTRINOS AND NEUTRAL BOSONS IN KAON DECAY. 183. 1 indexed citations

20.

Ohtake, S., T. Suzuki, Takeharu Yamanaka, et al.. (1984). Search for Heavy Neutrinos in Kaon Decay. 262. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact